A study to evaluate the oral valganciclovir as preemptive therapy for cytomegalovirus reactivation in pediatric hematopoietic stem cell transplant patients.
Phase of Trial: Phase IV
Latest Information Update: 04 Feb 2016
At a glance
- Drugs Valganciclovir (Primary) ; Ganciclovir
- Indications Cytomegalovirus infections
- Focus Therapeutic Use
- 04 Feb 2016 New trial record